Cover Image

Safety analysis of gepants for migraine treatment: A pharmacovigilance study using the FDA Adverse Event Reporting System ( FAERS ) database

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Hui Chen, Yan Li
Format:	Artículo Open Access
Published:	Wiley 2026
Subjects:	Headache: The Journal of Head and Face Pain
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Integrating gepants into clinical practice for the acute treatment of migraine
by: Richard B. Lipton, et al.
Published: (2026)

Unmet treatment needs in migraine: Results of the OVERCOME (US) study
by: Susan Hutchinson, et al.
Published: (2026)

Microneedles for the treatment of migraine and orofacial pain: A narrative review
by: Baicheng Cao, et al.
Published: (2026)

Cost per treatment responder analysis of atogepant compared to rimegepant for the preventive treatment of episodic migraine
by: Jessica Ailani, et al.
Published: (2024)

Effect of erenumab on the reversion from chronic migraine to episodic migraine in an Asian population: A post hoc analysis of the DRAGON study
by: Shuu‐Jiun Wang, et al.
Published: (2024)

A retrospective analysis of the use of candesartan for migraine prevention in adolescents
by: Irene Patniyot, et al.
Published: (2024)

The impacts of migraine on functioning: Results from two qualitative studies of people living with migraine
by: Rikki Mangrum, et al.
Published: (2024)

The effect of different exercise types on migraine frequency in individuals with migraine: A pilot study
by: Yunus Emre Meydanal, et al.
Published: (2025)

Advancing toward precision migraine treatment: Predicting responses to preventive medications with machine learning models based on patient and migraine features
by: Chia‐Chun Chiang, et al.
Published: (2024)

Delayed urticaria during treatment with anti‐ CGRP monoclonal antibodies in migraine
by: Christoph T. Berger, et al.
Published: (2026)

Long‐term reductions in acute headache medication use after eptinezumab treatment in patients with migraine and prior preventive treatment failures: Post hoc analysis of the DELIVER randomized trial
by: Anna Gryglas‐Dworak, et al.
Published: (2024)

Characterizing gaps in the preventive pharmacologic treatment of migraine: Multi‐country results from the CaMEO‐I study
by: Dawn C. Buse, et al.
Published: (2024)

Changes in brainstem habituation during onabotulinumtoxinA treatment in chronic migraine: A prospective case–control study
by: Gerlinde Freimark, et al.
Published: (2025)

A 3‐year follow‐up study of outcomes associated with patterns of traditional acute and preventive migraine treatment: An administrative claims‐based cohort study in the United States
by: Shivang Joshi, et al.
Published: (2024)

A 52‐week open‐label extension study to evaluate the safety and efficacy of oral rimegepant for the preventive treatment of migraine
by: David Kudrow, et al.
Published: (2025)

Genetic migraine disorders and the response to calcitonin gene‐related peptide antagonist treatment
by: Andrea M. Kuczynski, et al.
Published: (2025)

Blood serum levels of PACAP and migraine onset: A systematic review and meta‐analysis of observational studies
by: Guoliang Zhu, et al.
Published: (2024)

Long‐term effectiveness of eptinezumab in the treatment of patients with chronic migraine and medication‐overuse headache
by: Andrew Blumenfeld, et al.
Published: (2024)

Mapping the migraine: Intracranial recording of cortical spreading depression in migraine with aura
by: Graham A. McLeod, et al.
Published: (2025)

Chronotype in migraine and tension‐type headache: A population study
by: Da Eun Jung, et al.
Published: (2026)

Magnetoencephalography studies in migraine and headache disorders: A systematic review
by: Raghavan Gopalakrishnan, et al.
Published: (2024)

Comprehensive assessment of erenumab efficacy in participants with high‐frequency episodic migraine with at least one previously failed preventive treatment: The EMBRACE study
by: Gabriel Paiva da Silva Lima, et al.
Published: (2025)

Effects of fremanezumab on migraine‐associated symptoms and medication use in Japanese and Korean patients with episodic migraine: Exploratory endpoint analysis of a multicenter, randomized, double‐blind, placebo‐controlled trial
by: Muneto Tatsumoto, et al.
Published: (2024)

Patient reported outcomes and the real‐world use of calcitonin gene–related peptide medications in migraine
by: Samuel K. Peasah, et al.
Published: (2024)

Novel optimization of multi‐mechanistic approaches for the acute treatment of a migraine attack: A review
by: Stephen Silberstein, et al.
Published: (2026)

Patient preferences for the preventive treatment of episodic migraine in the United States: A discrete‐choice experiment
by: Richard B. Lipton, et al.
Published: (2025)

Patient preferences for preventive migraine treatments among Canadian adults: A discrete choice experiment
by: Joanna K. Bougie, et al.
Published: (2024)

Do patients with migraine and obesity receive different treatments? Insights from real‐world data
by: Keshet Pardo, et al.
Published: (2025)

The impact of the migraine treatment onabotulinumtoxinA on inflammatory and pain responses: Insights from an animal model
by: Philip Victor Reducha, et al.
Published: (2024)

Effectiveness and acceptability of oral migraine preventives: A prospective, observational study
by: Hedda S. Riise, et al.
Published: (2026)

Association between migraine and exclusive breastfeeding: A cross‐sectional study
by: Manav V. Vyas, et al.
Published: (2024)

Metaphorical use of “headache” and “migraine” in media: A longitudinal study of 1.3 million articles in major publications
by: Pengfei Zhang, et al.
Published: (2024)

Rates and risk factors for migraine progression using multiple definitions of progression: Results of the longitudinal OVERCOME ( US ) study
by: Dawn C. Buse, et al.
Published: (2025)

Sequential administration of peripheral nerve blocks and onabotulinumtoxinA for the treatment of chronic migraine and other headache disorders—A retrospective tolerability and safety study
by: Christopher C. Anderson, et al.
Published: (2024)

Behavioral interventions for migraine prevention: A systematic review and meta‐analysis
by: Jonathan R. Treadwell, et al.
Published: (2025)

Memantine as a migraine prophylactic agent in adolescents: A retrospective analysis
by: M. Ismail K. Yousaf, et al.
Published: (2025)

Engagement and predictors of use of a smartphone app for migraine self‐management: A secondary analysis of the EMMA trial
by: Stefanie Lysk, et al.
Published: (2025)

A machine learning‐driven transcriptomic study reveals the key role of Romo1 in reversing central sensitization through stellate ganglion block in migraine: An interventional study based on a recurrent migraine rat model
by: Fei Yang, et al.
Published: (2025)

Comparative analysis of real‐world acute prescription migraine therapy outcomes: Insights from the HeAD – US study
by: Devin Teichrow, et al.
Published: (2026)

Randomized controlled trial of intravenous dexamethasone to prevent relapse in the treatment of migraine in a pediatric emergency department
by: Geneviève Tourigny‐Ruel, et al.
Published: (2026)